Research on Marine Compounds and Inflammation
A special issue of Marine Drugs (ISSN 1660-3397). This special issue belongs to the section "Marine Pharmacology".
Deadline for manuscript submissions: 1 October 2025 | Viewed by 257
Special Issue Editor
Interests: bioeconomy; sustainability; marine plants; macroalgae; rare diseases; inflammation; post-genomics; omics
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Although inflammation is an essential biological response to harmful stimuli, chronic inflammation is connected to numerous diseases, such as cancer, neurodegenerative disorders, and autoimmune conditions. Marine ecosystems are a source of bioactive compounds that have potential anti-inflammatory effects that have not yet been explored. The aim of this Special Issue is to highlight the most recent developments in the discovery, characterization, and mechanisms of action of marine-derived anti-inflammatory agents. We welcome original research and review articles focusing on the identification of novel compounds from marine organisms, their biosynthetic pathways, and their molecular targets in inflammatory processes. Studies employing in vitro, in vivo, and omics approaches to elucidate the potential of these compounds are particularly encouraged. Our goal is to bring together cutting-edge research in this field to promote new perspectives on marine natural products as sustainable and effective remedies for inflammation-related diseases.
Dr. Michela Geminiani
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- anti-inflammatory compounds
- marine bioactive metabolites
- inflammation
- bioactive secondary metabolites
- molecular targets of inflammation
- marine algae
- inflammatory pathways
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
